UK and EU pharmaceutical sellers can now apply to PharmaBatch
UK and EU pharmaceutical wholesalers can apply to PharmaBatch. Learn the seller registration steps, licence checks and private batch and RFQ workflow.
Read guideFor pharmaceutical sellers
Marketplace for eligible EU and UK pharmaceutical wholesalers
Eligible EU-27 and UK pharmaceutical sellers can privately present surplus or short-dated batches with actual expiry data, use buyer tools and answer RFQs after approval.
Seller location eligibility
Only legal entities established in one of the 27 EU member states or the United Kingdom may apply as sellers. This refers to the seller’s registered legal-entity location—not the medicine’s country of origin. Seller tools remain unavailable while the application is pending.
One seller account, two capabilities
Verified sellers can use the buyer workflow to request listed stock or publish RFQs. They can also list batches and respond to other buyers. A buyer-only account cannot sell.
Apply before listing stock
Submit current organisation and wholesale authorisation details for review. EU seller checks use the issuing national competent authority and EMA-operated EudraGMDP records. UK seller checks use MHRA wholesale distribution authorisation (WDA(H)) and GDP records, including MHRA-GMDP and the official wholesale-site register. Marketplace approval does not grant import or export permission; each proposed route remains subject to applicable requirements and transaction review.
Match the exact pack
Choose the correct record from the private medicine directory before entering the available quantity, supplier net price per pack, country of origin, expiry, storage conditions and batch number where relevant.
A controlled route for eligible surplus stock
If a real batch remains saleable under the seller’s quality procedures and applicable requirements, the seller can privately present its exact expiry, quantity, origin, storage conditions and supplier net price. Approved buyers see a separate final product price that includes the 6.5% marketplace fee; exact counterparty prices remain commercially confidential. Buyers can assess the remaining shelf life against their destination and operational requirements. This may give eligible surplus or short-dated inventory another route before it becomes obsolete or is written off. A listing never guarantees a buyer, sale or transaction acceptance, and the seller remains responsible for withdrawing stock that no longer qualifies as saleable.
Submit an offer for review
New offers enter an administrator queue before they are shown as live stock to approved marketplace members. The seller remains responsible for keeping the listing accurate and current.
Respond to buyer RFQs
Open buyer requests show the medicine, pack, quantity, destination and other stated requirements. Submit the quantity, supplier net price, origin, expiry and storage terms you can offer.
Confirm direct requests
When a buyer requests quantity from one of your live offers, confirm or decline it. A confirmed request—or a buyer-selected RFQ response—moves to marketplace review before an order record is created.
Related professional guides
Continue with an evidence-led checklist.
Pharmaceutical surplus and short-dated stock: a controlled B2B workflow
A practical workflow for eligible EU and UK pharmaceutical sellers to present surplus or short-dated batches without exposing sensitive stock and price data.
Read guideWDA vs GDP certificate vs MIA: what each pharmaceutical record means
Understand the difference between an EU Wholesale Distribution Authorisation, GDP certificate and Manufacturing and Importation Authorisation.
Read guideGive real inventory a controlled route to verified demand
Eligible EU-27 or UK legal entities can apply to present available, surplus or short-dated batches privately after seller verification.
Apply as a verified seller